The optimal timing of tracheostomy in patients with severe traumatic brain injury (TBI) is controversial; observational studies have been challenged through confounding by indication, and interventional studies have rarely enrolled patients with isolated TBI.
P atients experiencing severe traumatic brain injury (TBI) often require mechanical ventilation in intensive care units (ICUs) as a component of their initial care after their injury. While in the ICU, they commonly undergo tracheostomy to ensure a patent airway when level of consciousness remains persistently depressed and thereby facilitate liberation from mechanical ventilation. 1, 2 However, there is substantial variability in the rate of tracheostomy and its timing among different institutions.
3Y7
The foreseen benefits of performing early tracheostomy (ET) for patients undergoing prolonged mechanical ventilation include improved patient comfort due to reduced oropharyngeal irritation 8 , improved pulmonary toilet that might also accelerate liberation from mechanical ventilation, and a possible resultant decrease in the risk of pneumonia and ventilatorinduced lung injury. 9, 10 The concern with routinely performing ET is that some patients might be unnecessarily exposed to potential complications, including bleeding as well as acute and chronic airway injury. 1, 11 The benefit of ET in the general medical-surgical critically ill patients remains unproven despite multiple randomized controlled trials (RCTs) . 12Y17 However, isolated TBI patients represent a unique subpopulation. In contrast to other critically ill patients, isolated TBI patients often require little or no assistance from mechanical ventilators and might be liberated more promptly from the ventilator once the airway is secured with a tracheostomy. 1, 11 Therefore, it is important to study tracheostomy timing in isolated TBI separately.
In this context, we conducted a cohort study using data derived from the American College of Surgeons' (ACS) Trauma Quality Improvement Program (TQIP) to ascertain whether ET, compared with late tracheostomy (LT), in patients with isolated TBI is associated with a shorter duration of mechanical ventilation as well as shorter ICU and hospital length of stay.
PATIENTS AND METHODS

Study Design
We completed a retrospective cohort study of patients admitted to hospital with TBI who received tracheostomy during their acute hospital stay as recorded by the ACS TQIP. Outcomes were compared between patients who underwent tracheostomy within 8 days of admission and patients whose tracheostomies were performed later. The study was approved by the research ethics board of Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.
Data Source
TQIP was established to allow an opportunity for trauma centers to compare their process of care and outcomes with other centers. 18 The program includes more than 150 Level I and II trauma centers in the United States and Canada. More than 100 patient and hospital variables are recorded including patient demographics, premorbid conditions, injury type, mechanism and severity, prehospital and emergency department physiologic variables, in-hospital procedures, and outcome information, including in-hospital morbidity and mortality. 18 The reliability of the data is ensured using intensive training mechanisms for data abstractors and interrater reliability audits of participating sites. 18, 19 Inclusion into TQIP requires at least one valid trauma International Classification of DiseasesV9th Rev.VClinical Modification code in the range of 800 to 959, excluding late effects of trauma (905Y909). 18 
Cohort
We identified patients 16 years or older who were admitted between January 1, 2009, and December 31, 2011, to a TQIP hospital with head Abbreviated Injury Scale (AIS) score of 3 or greater. The study only included patients who received tracheostomy during their acute hospital stay. To ensure homogeneity of our cohort, exclusion criteria were severe injuries (AIS score 9 2) in any other body region, penetrating TBI, and previous advanced directives to withhold life-sustaining interventions.
Exposure
Patients undergoing tracheostomy were identified by the presence of one of the following International Classification of DiseasesV9th Rev.VClinical Modification procedure codes: 31.1 (temporary tracheostomy), 31.21 (mediastinal tracheostomy), or 31.29 (other permanent tracheostomy). Tracheostomy timing was defined as the number of days between hospital admission and the tracheostomy procedure and was categorized into two periods as follows: early (if performed within 8 days after admission) and late (if the performed on or after the ninth day of admission). We chose this cutoff point to define the exposure to ensure consistency with recently published RCTs and because the median time to tracheostomy in our cohort was 9 days. 20 We also explored other thresholds by dividing tracheostomy timing into quartiles in a sensitivity analysis. Only the first record of tracheostomy was analyzed for each patient during the index hospitalization.
Outcomes
The primary outcome was duration of mechanical ventilation in days. The following secondary outcomes were analyzed: (1) ICU length of stay in days, (2) hospital length of stay in days, (3) in-hospital mortality, (4) hospital-acquired pneumonia, (5) deep venous thrombosis, (6) pulmonary embolism, (7) decubitus ulcers. Detailed definitions of secondary outcomes are provided in the Supplementary Appendix (Supplemental Digital Content 1, http://links.lww.com/TA/A329). 21 
Covariates
The following patient-level covariates were considered for inclusion into the adjusted analyses: age, sex, race, comorbid illnesses, injury mechanism and severity (as measured by head AIS score), Glasgow Coma Scale (GCS) motor score, type of intracranial lesion, presence of systolic hypotension on admission, whether a neurosurgical procedure (craniotomy and intracranial pressure[ICP]) monitor insertion) was performed, and insurance status. To identify acute intracranial lesions, we used AIS predot codes (1998 version) that reflect injuries to the intracranial structures (Supplementary Appendix Table S1 , Supplemental Digital Content 1, http://links.lww.com/TA/A329). To characterize the hospital environment, which may influence the relation between process of care and outcome, we classified centers based on the following factors: volume of severe TBI patients per hospital during the study period (divided into quartiles), teaching status, number of hospital beds, hospital type (nonprofit vs. for profit), and ACS or state trauma center designation level (Level I vs. II).
Statistical Analysis
We calculated standardized differences to compare baseline characteristics between patients who received ET versus LT. Standardized differences represent the mean difference as a percentage of the standard deviation (SD). To estimate these, differences between groups are divided by the pooled SD of the two groups. The advantage of standardized differences is that they are not as sensitive to sample size as traditional tests and provides a sense of the relative magnitude of differences. 22, 23 Standardized differences of greater than 0.1 are typically considered meaningful. 22, 23 Propensity scores to estimate the probability, based on individual and hospital characteristics, that patients would be selected to undergo ET were developed using logistic regression. The model included all of the previously mentioned covariates (Supplementary  Appendix Tables S4 and S5 , Supplemental Digital Content 1, http://links.lww.com/TA/A329).
To minimize potential treatment selection bias, propensity score matching was performed using a 1-to-1 matching technique without replacement. 24 The procedure sorted all patients according to the propensity scores and matched each exposed (ET) patient to an unexposed (LT) patient within 0.2 SD of the logit of the propensity score. 25 If multiple unexposed controls matched to an exposed patient, then one control was randomly selected. After a patient was matched, that match was not reconsidered. The covariate balance after matching was assessed by calculating the standardized difference of the mean or proportion for each covariate, with a standardized difference of G0.1 indicating sufficient balance. 26 Within the propensity-matched cohort, the statistical significance of the differences in outcomes was assessed using McNemar's test to compare proportions and Wilcoxon signed-rank test to compare distributions. 26, 27 Taking into account the matched nature of the data, we calculated a rate ratio (RR) and 95% confidence interval (CI) assuming a negative binomial distribution for each of the following outcomes: mechanical ventilation days as well as ICU and hospital lengths of stay. 28 Odds ratios and 95% CIs were estimated for binary outcomes.
Multiple subgroup and sensitivity analyses were performed, as described in the Supplementary Appendix (Supplemental Digital Content 1, http://links.lww.com/TA/A329). To address potential immortal time bias, we first examined the sensitivity of the results after excluding those who died inhospital from the initial cohort and repeating the analysis using the same propensity score model and matching algorithm. Next, using the entire cohort of patients (including the previously unmatched group), we performed multivariate proportional hazards regression, treating tracheostomy as a time-dependent exposure. Patients were entered into the model as a step function starting on the day of tracheostomy, but the hazard of event (e.g., liberation from mechanical ventilation or discharge from hospital) for the patient was indexed to the time since admission.
29Y31
This technique ensured that hazard ratios (HRs) were not distorted based on comparisons before the patient actually received tracheostomy. 29, 31 For this multivariable model, we used a sandwich-type robust variance estimator to correct for possible clustering (i.e., correlation) of patients within hospitals. 32 It is plausible that residual confounding by indication might create a spurious association between timing of tracheostomy and outcome at the patient level. To overcome this limitation, we asked a second question: do centers with high rates of ET have shorter duration of mechanical ventilation and length of stay? To accomplish this objective, we divided hospitals into quartiles based on their specific rate of ET use among TBI patients. Then, we evaluated this factor as a determinant of mechanical ventilation days as well as ICU and hospital lengths of stay for their TBI population undergoing tracheostomy (regardless of timing) after adjusting for patient-and hospitallevel characteristics.
Finally, we explored the impact of possible unmeasured residual confounding to assess whether the observed differences in the primary outcome (i.e., mechanical ventilation days) could be fully explained by an unmeasured confounder. 33 All analyses were performed using SAS software (version 9.3, SAS Institute, Cary, NC), and statistical significance was defined as a two-tailed p G 0.05.
RESULTS
Characteristics of Study Cohort
The study cohort consisted of 1,811 adults with isolated TBI who underwent tracheostomy at 135 Level I and II trauma centers participating in ACS TQIP. The median time to tracheostomy was 9 days (interquartile range [IQR] 6Y12 days) from admission. Table 1 shows selected baseline characteristics of the study patients (a more detailed description is provided in Table S2 and S3 in the Supplementary Appendix, Supplemental Digital Content 1, http://links.lww.com/TA/A329). The ET (e8 days; median, 6 days; IQR, 4Y7 days) patients were younger, had a lower comorbidity burden, experienced more severe TBIs, were more likely to have commercial insurance, and were treated at hospitals with a higher volume of severe TBI patients than the patients who received LT (98 days; median, 12 days; IQR, 10Y15 days). Conversely, patients who received LT were more likely to experience subdural hematomas and fall-related injuries. There was no significant difference between the two groups in the frequency of craniotomy or ICP monitoring.
Propensity-Matched Cohort
Propensity score matching generated 571 distinct pairs (n = 1,142). Within the matched cohort, all the individual and hospital characteristics were well balanced (Tables S4 and S5 in the Supplementary Appendix, Supplemental Digital Content 1, http://links.lww.com/TA/A329). After matching, ET was associated with fewer mechanical ventilation days (RR, 0.70; 95% CI, 0.66Y0.75), shorter ICU stay (RR, 0.70; 95% CI, 0.66Y0.75) and shorter hospital length of stay (RR, 0.80; 95% CI, 0.74Y0.86) ( Table 2) . ET patients had 30% less mechanical ventilation days, 30% shorter ICU stay, and 20% shorter overall hospital stay, compared with LT patients. ET was also associated with significantly lower odds of pneumonia, deep venous thrombosis, and decubitus ulcer, but no significant difference was found in the odds of pulmonary embolism or in-hospital mortality (Table 3) .
Among the ET group, the unmatched patients had a higher probability of receiving ET compared with the matched patients (mean propensity score, 0.76 vs. 0.51; p G 0.0001), which may reflect lower decision uncertainty in patient selection for ET. In addition, the unmatched ET patients had similar (median mechanical ventilation days, 10 days vs. 10 days, respectively, p = 0.37; median ICU stay, 13 days vs. 13 days, respectively, p = 0.69) or more favorable outcomes compared with matched patients (median hospital stay, 18 days vs. 20 days, respectively, p = 0.02).
Sensitivity Analysis
The results of the sensitivity analyses are detailed in the Supplementary Appendix (Supplemental Digital Content 1, http://links.lww.com/TA/A329). Results were consistent across multiple patient subgroups ( Figure S1 in the Supplementary Appendix, Supplemental Digital Content 1, http://links.lww.com/TA/A329). Similar resultswere found after excluding deathsfromthe initial cohort and repeating the propensity score matching (Tables S6  and S7 in the Supplementary Appendix, Supplemental Digital Content 1, http://links.lww.com/TA/A329). Using the entire cohort, we repeated the analysis using multivariate proportional hazards regression considering tracheostomy timing as a time-dependent variable. ET was found to be associated with a higher likelihood (i.e., hazards) of liberation from mechanical ventilation, discharge from the ICU, and discharge from the hospital (Table 4) . When the 135 hospitals were ranked into quartiles based on their ET use rate, the results were consistent with the individual-level analysis. Compared with the quartile with the lowest ET rate (Quartile 1), the hospitals with the highest rate of ET use (Quartile 4) were associated with shorter mechanical ventilation (RR, 0.67; 95% CI, 0.60Y0.74), ICU stay (RR, 0.68; 95% CI, 0.62Y0.76), and hospital stay (RR, 0.70; 95% CI, 0.62Y0.79) ( Table 5) . Results were consistent after dividing tracheostomy timing into quartiles instead of two exposure groups (Tables S8 in the 
Influence of Unmeasured Confounding
From the time-dependent proportional hazards model, the adjusted HR for liberation from mechanical ventilation associated with ET versus LT was 2.04 (95% CI, 1.83Y2.27). *HR compares ET (G8 days) with LT (98 days). HR 9 1 implies that there is a higher likelihood of event (liberation from mechanical ventilation or discharge) with ET. Figure 1 summarizes the method used to assess whether an unmeasured binary confounder would account for an HR of this magnitude. 34 For example, if the prevalence of an unmeasured confounder was 10% in the ET group (curved blue line) and 60%, 75%, or 90% in the LT group, then the confounder itself could explain the observed difference in the likelihood of liberation from mechanical ventilation between both groups only if it decreased the likelihood (hazard) of liberation from mechanical ventilation by 93% (HR, 0.07), 73% (HR, 0.27), and 60% (HR, 0.4), respectively.
DISCUSSION
In this observational study, we found that ET was associated with reduced duration of mechanical ventilation and shorter ICU and hospital stays. The findings were consistent when we used multiple analytic approaches to examine these relations. Our analysis also suggests that ET is associated with lower risks of pneumonia, deep venous thrombosis, and decubitus ulcer, with a trend toward a lower risk of pulmonary embolism. However, our study did not find an association between tracheostomy timing and in-hospital mortality in patients with isolated TBI.
The most common indication for tracheostomy in the ICU is to provide long-term airway access for prolonged mechanical ventilation and to allow a conduit for suctioning. 12, 35 Performing ET in the critically ill is postulated as a mechanism to improve clearance of respiratory secretions, which might accelerate liberation from mechanical ventilation, and thereby reduce the risk of pneumonia and ventilator-induced lung injury. 36, 37 Earlier liberation from mechanical ventilation may also promote earlier ambulation and hence lower the risk of thromboembolism and decubitus ulcers. 31 Nevertheless, previous studies provide little guidance regarding optimal tracheostomy timing. A systematic review of several RCTs showed no evidence of benefit for ET versus LT in the general medical-surgical critically ill patients and a marked excess in the procedure rate among patients randomized to the ET. 12, 20 However, the indications for mechanical ventilation and the underlying lung mechanics are variable in different patient subgroups. In isolated TBI patients, reduced consciousness and depressed protective airway reflexes cause airway protection to be the primary indication for endotracheal intubation with little need for support from the ventilator to achieve adequate gas exchange. 2, 11 Hence, faster liberation of these patients from mechanical ventilators could potentially be achieved once the airway is secured with a tracheostomy tube.
Previous studies of tracheostomy timing in TBI have not shown consistent or conclusive results.
11,13Y17 Our findings agree with previous studies that showed a significant association between ET and shorter mechanical ventilation and ICU stay in addition to reduced risk of pneumonia in TBI patients 14, 16 but contrast with others that did not reveal such significant associations, found no effect on overall hospital stay, and/or showed higher mortality with ET.
11,13,15,17 However, previous studies experienced a number of limitations, which may explain their contradictory results. In addition to the small sample size in the majority of the previous studies, none of the studies was restricted to patients with isolated TBI who have no significant multisystem injuries.
11,13Y17 Multisystem trauma might increase the risk for long-term ventilator dependency and alter the unique potential advantage of ET in TBI patients. 38, 39 Moreover, the surprising finding of higher mortality with ET in some of the previous studies suggests that residual confounding may have significantly biased their results. In addition to the focused primary diagnosis of this cohort, the strengths of our study include very large sample size and the use of multiple analytic techniques to address the potential biases that commonly confound tracheostomy timing studies, most importantly confounding by indication and immortal time bias. Such biases are commonly ignored in these studies. In our primary analysis, we used propensity score matching on many measured individual-and hospital-level characteristics to obtain a well-balanced cohort and minimize confounding by indication. Immortal time bias, which is also known as survivor-treatment bias, can confound such studies because the outcome of interest (i.e., liberation from mechanical ventilation, discharge from ICU, or death) could not occur before a certain time in the LT group because of the exposure definition. 29 To account for this bias and address the censoring of outcomes by mortality, we used proportional hazards regression considering tracheostomy timing as a timedependent exposure. 29Y31 In addition, clustering of TBI management strategies at different hospitals could lead to a clustering of the patient outcomes. In our proportional hazards model, we also accounted for potential correlation between patients within hospitals.
Several limitations should be considered when interpreting the results of our study, including the inability to precisely ascertain certain secondary outcomes, such as pneumonia and deep venous thrombosis. However, there is no compelling reason to believe that information on these outcomes was gathered differently between the exposure and control groups. Furthermore, nondifferential misclassification tends to bias point estimates toward finding no difference, leading to more conservative results. 40 It is noteworthy that statistical methods cannot adjust for unmeasured confounding factors. Our database did not include information on certain factors that may influence the decision to perform tracheostomy, such as physician judgment and the patient's or patient's family's approach to life-sustaining interventions. Therefore and given the possibility of similar distributions of unmeasured confounding among different hospitals, we repeated the analysis after changing the exposure definition to be the hospital-specific rate of ET use. This approach provided similar results to the individual-level analysis. We also explored the impact of a hypothetical unmeasured confounder in a sensitivity analysis. The analysis suggests that the observed difference in outcome between the two groups could be accounted for by a single unmeasured variable or multiple confounding variables acting in concert only if this confounder (e.g. frailty) was approximately 2 to 10 times more prevalent in the control group and this confounder decreased the likelihood of liberation from mechanical ventilation by 93% to 54%, respectively. Not only such hypothetical confounder of this magnitude seems implausible in our cohort, but they could also increase the difference.
Limited by our database, we could not capture patients who were potential candidates for tracheostomy but were successfully liberated from mechanical ventilation without ever undergoing this procedure. Our study provides guidance on the timing of the tracheostomy procedure in TBI patients rather than patient selection. Therefore, the findings of our analysis suggest that ET might reduce in-hospital morbidity and accelerate ambulation only among those who already have indications for this procedure. Because of the low number of in-hospital deaths in our cohort, we cannot conclusively exclude a mortality difference. Future studies to address this question will likely require a much larger sample size to detect whether a small survival advantage for ET may exist in this patient population. AUTHORSHIP A.S.A. and A.B.N. designed the study, created the cohort, and are responsible for the analysis. All authors contributed to the data interpretation, manuscript preparation, and critical revision. Although the ACS administers the TQIP, the authors of this study are solely responsible for the analyses and conclusions presented here. I think it's safe to say that the majority of us who take care of trauma patients are probably in favor of tracheostomy, and I would even venture to say that we're probably all in favor of early tracheostomy.
At this very meeting, the Memphis group is presenting data about the benefits of early tracheostomy in polytrauma patients. Other centers are talking about expanding the indications for early tracheostomy into populations that were formerly frowned upon such as in patients who've recently had cervical fixation surgery.
It's inescapable that there is a lot of bias when it comes to timing of tracheostomy, and I think that one of the issues that has permeated the literature, as Dr. Alali pointed out, is that there is no firm evidence in our body of literature supporting the timing of tracheostomy.
Certainly there is nothing in the literature regarding the timing of tracheostomy in traumatic brain injury patients, although again I would probably venture a guess that the majority of us in the room think that tracheostomy is absolutely necessary to care for the most severely injured traumatically brain injured patients.
To address some of these questions, the Sunnybrook group has utilized TQIP, which is the Trauma Quality Improvement Database, to identify a large cohort and they broke that into early and late tracheostomy groups.
Their primary endpoint was cessation of mechanical ventilation, but their secondary endpoints were also rather ambitious: length of stay in both the hospital and the ICU, mortality and a host of nosocomial complications such as pneumonia, DVT, PE, decubitus ulcer, et cetera.
In accordance with our biases, it came as no surprise that the data showed that early tracheostomy really was successful in reducing all of those secondary endpoints, and they actually met the primary endpoint.
Due to the complexities of the statistics, the paper was somewhat difficult for me to read, but it is apparent that the statistical processes are very, very thorough. I also think it's apparent that the authors went to great lengths to try and minimize bias and to try and keep the manuscript as clean as possible.
I don't have a lot of questions for you but I do have some philosophical ones and maybe a few translational ones as well.
I have some concerns with the whole concept of propensity scoring, which is a new and exciting area of statistics. Unfortunately, in some centers or some papers I read lately, it seems like it is being utilized more as a brain rather than a tool.
To create the propensity score, a series of multiple regression analyses were done and this creates an equation, if you will, then all the patients were run through the equation which essentially gave them a score or propensity score.
Following the scoring, matching was done and you can see that there were over 700 patients excluded, which left the so-called matched cohorts. The concept is that in the matched patients, the confounding variables would sort of cancel each other out.
I think one of the problems with the propensity scoring is that the very heavy processing of the data sometimes can strip away things that the investigators may not be aware of.
So my question is could you elaborate a little bit on how robust was your analysis of unmeasured confounding variables? Secondly, many times I think it is an inescapable fact that the decision to perform a tracheostomy in somebody with a very severe traumatic brain injury is not so much a medical decision but more of an ethical decision.
I've often heard it described when you perform a tracheostomy in somebody with severe traumatic brain injury it's ''immortalization'' because really you are confining them to a long-term existence in an L-TAC or a nursing home.
It's also inescapable that many of these patients have withdrawal of support when the specter of long-term care with a feeding tube and a tracheostomy is offered to the family.
I know you can't really comment from a data analysis standpoint, but what do you think would have happened if those patients who had therapy withdrawn at the family's request were able to get enrolled in the studythat is, what about the path not taken? Had they been trached, how do you think that would have affected your secondary endpoints? I would assume that the patients who had withdrawal of care probably were in the higher end of the head AIS scoring system, although I doubt you have that data.
You did touch on it in the presentation that patients with traumatic brain injury often don't have pulmonary dysfunction as much as either airway protection issues or another very common oneYand this is very difficult for trauma surgeonsYis will do they pulmonary toilet? Will they do incentive spirometry? We could extubate them only to re-intubate them two or three days later when they have progressive atelectasis, recurrent respiratory failure and pneumonia, et cetera.
Patients who are trached early and immediately go to trach mask and often mistakenly viewed that the decision to perform early tracheostomy is an error in judgment, that you shouldn't have trached that patient since they were liberated from mechanical ventilation so easily. I look at it the exact opposite way and I think that's an important group to consider. One anecdotally thing that a lot of us have seen is that when you perform a trach in this cohort and they are rapidly freed from mechanical ventilation, it seems likely that these patients get decannulated sooner than the others.
I was wondering if you could comment a little bit on decannulation rates. Is that soft evidence that in retrospect perhaps the tracheostomy may not have been indicated? Lastly, I would just like to commend you on a nice presentation and I look forward to your center's further work utilizing these statistical analysis to use the TQIP database.
I think TQIP is a wonderful risk adjusted database and this kind of thoughtful data mining is really necessary so we can focus in on important outcomes in trauma patients.
Dr. Ajai Malhotra (Richmond, Virginia): Despite propensity scoring, which is the chicken, which is the egg? If a patient comes and gets a pneumonia on Day 3, the chances are that that pneumonia is going to prevent him from going for an early tracheostomy so he will be classified as higher incidence of pneumonia in a late tracheostomy. Despite propensity scoring, I doubt if that confounding problem can be removed. Second, at the center level, since so many of the outcomes are better, is it possible that the early tracheostomy is a marker of better processes of care at those centers, which you are identifying in your quartiles, rather than the tracheostomy itself responsible for all the benefits?
Dr. Garth Utter (Sacramento, California): My question has already been brought up by the discussant as well as the previous questioner. To what extent do you think residual confounding can explain these findings? It seems that most of the findings may merely reflect associations with just bad brain injury. And what information would you use if it were available to sort that out?
Dr. Lovenia Stam (Ogden, Utah): My question is did you account for your decreased length of stay and your decreased mechanical ventilation for transfers to an L-TAC out of your facility or to a different facility?
Dr. Aziz Alali (Toronto, Canada): In terms of our choice for propensity score matching as the primary analytic method, there were a number of reasons:
Propensity score methods allow simultaneous control for confounding by several variables in situations where conventional multivariable models might not be appropriate, owing to the rareness of outcomes. Because 10 events per covariate is usually considered to be a minimum requirement for stable estimates in multivariable models, propensity score analyses combining multiple covariates into a single score are especially desirable if the outcome is rare. A simulation study comparing propensity score with multivariable regression models concluded that propensity score analysis performed better in situations with less than 8 outcomes per covariate. In our study, many outcome measures were rare (e.g. mortality and pulmonary embolism) relative to the large number of potential confounder that we tried to control for.
Another advantages of propensity score methods over conventional multivariable models is that one can explicitly determine the degree to which one has balanced measured characteristics between treated and untreated subjects (as shown in our study by comparing matched exposure and control groups using standardized differences, Table S4 and S5).
By matching subjects based on their probability to receive treatment, propensity score matching has an intuitive potential to match only patients in whom there was more decision uncertainty regarding assignment to the exposure (i.e. early tracheostomy; ET) vs. the control (i.e. early tracheostomy; LT). In addition, previous studies have shown that propensity score matching results in the comparison of treated and untreated subjects who are more similar than does other propensity score methods. Among the ET group in our cohort, the unmatched patients had a higher probability of receiving ET compared with the matched patients (mean propensity score 0.76 vs. 0.51, pG0.0001), which may reflect lower decision uncertainty in patient selection for ET. In addition, the unmatched ET patients had similar (median mechanical ventilation days: 10 vs. 10 days, respectively; median ICU stay: 13 days vs. 13 days, respectively) or more favorable outcomes compared with matched patients (median hospital stay: 18 days vs. 20 days, respectively).
Also, we used multiple statistical techniques other than propensity score matching (e.g. cox proportional hazards and generalized estimating equations) that utilized the entire cohort of patients (i.e. without excluding the unmatched subgroup). The results were similar to propensity score matching analysis.
In terms of residual confounding, we acknowledge this potential limitation despite the consistent results across multiple statistical methods and techniques. However, the ''influence of unmeasured confounding'' analysis suggests that the observed difference in outcome between the two groups could be accounted for by a single unmeasured variable, or multiple confounding variables acting in concert, only if this confounder was approximately 2Y10 times more prevalent in the control group and this confounder decreased the likelihood of liberation from mechanical ventilation by 93Y54%, respectively. Not only such hypothetical confounders of this magnitude appear implausible in our cohort, but they could also increase the difference. Nevertheless, we acknowledge that this study as any other observational study is hypothesis generating, and its results ''suggest'' that ET is a mechanism to reduce in-hospital morbidity for TBI patients.
I agree that there is an interconnection between the decision to perform tracheostomy for TBI patients and their perceived long-term prognosis. Perhaps, this connection was a major barrier that prevented clinicians from including their TBI patients in randomized trials of tracheostomy timing. Unfortunately, this is not captured by our data and we cannot rule out its impact on the results. However, we attempted to adjust for important differences in case-mix including important prognostic factors like age and injury type and severity. In addition, because of the likelihood of similar distribution of unmeasured confounding among different hospitals, we repeated the analysis after changing the exposure definition to be the hospital-specific rate of ET use. This approach provided similar results to the individual-level analysis. Nevertheless, only methodologically rigorous prospective studies can eliminate this potential bias.
Because higher rates of ET could be a marker of differences in other processes of care, we compared the distribution of other processes of care (e.g. ICP monitoring rate) among hospitals with high ET rates and hospitals with lower ET rates. We found that the distribution of these processes of care was similar among both hospital groups (e.g. rate of ICP monitoring among severe TBI patients was similar in both hospital groups); which suggests that timing of tracheostomy is independently associated with lower in-hospital morbidity.
In terms of having better outcomes in the ET group as a marker of a less severe primary injury, the Table 1 shows actually quite the opposite. The ET group were more likely to be in the severe TBI group. They had lower GCS scores on admission, and higher head AIS scores.
I would like to thank the AAST for the privilege to present our study, and thank you all for your comments.
